Niroshana Anandasabapathy
- Weill Cornell Medicine · Dermatology (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #9,745
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10482358Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Dermatology
NIH Funding · FY2026
Linked Award Amount
$2.1M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#9,745
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Niroshana Anandasabapathy as a PI. Multi-PI records show the full award amount for context.
- 1R01CA316570-01R01Contact PIAnti-PD1 driven tissue pathogenesis, towards preventing and treating irAE toxicity during cancer therapyWeill Cornell Medicine · Dermatology (NIH department code)$733.1Kaward amount
- 5R01AR083208-03R01Contact PINew mechanisms governing skin tissue residency memory T cellsWeill Cornell Medicine · Dermatology (NIH department code)$705.2Kaward amount
- 5R01AR080436-05R01Contact PIInterrogating unique DC adaptations to tissue to promote barrier immunity and toleranceWeill Cornell Medicine · Dermatology (NIH department code)$691.5Kaward amount
Award organization
Organizations that administered FY2026 awards listing Niroshana Anandasabapathy as a PI.
FY2026 award administered by Weill Cornell Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardWeill Cornell Medicine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #8977
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder